Chronic Noninvasive Ventilation for COPD May Improve Blood Gases, HRQoL
A new Cochrane review of 21 published studies examined effect of chronic noninvasive ventilation for stable and post-exacerbation COPD.
Chronic Obstructive Pulmonary Disease
Multidisciplinary COPD Screening May Improve Smoking Cessation Efforts
A pilot study of diverse health professionals explored the feasibility and effectiveness of screening and educating patients at high-risk for COPD.
COPD Associated With Concurrent Use of Electronic, Conventional Cigarettes
The increased risk for COPD from dual use of electronic and conventional cigarettes was especially notable in men older than 65.
Generic Version of Perforomist Now Available
The first authorized generic version of Perforomist® (formoterol fumarate inhalation solution; Mylan Specialty L.P.) 20mcg/2mL has been made available by Teva Pharmaceuticals.
Preoperative LAMA/LABA Reduces Surgical Complications in Lung Cancer With COPD
Preoperative use of a LAMA with a LABA was associated with significant improvements in lung function compared with use of LAMA alone in patients with lung cancer and COPD.
Metformin May Slow Emphysema Progression, Systemic Consequences
Metformin has demonstrated potential for slowing emphysema progression and its systemic consequences.
Single-Inhaler Triple Therapy Reduces Composite AE Risk vs Dual Therapy in COPD
Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations.
Addressing the Controversy of “Pre-COPD”: A Point/Counterpoint Q&A
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
Triple Therapy Combination Reduces COPD Exacerbations, Death Risk
Patients with moderate to very severe COPD who received triple fixed doses of an inhaled glucocorticoid, LAMA, and LABA had fewer exacerbations compared with those taking 2 of the 3 medications.
Asthma, COPD Medication Adherence Increased During Pandemic
Medication adherence for asthma and COPD has increased during the COVID-19 pandemic.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...